Activation of the p62-Keap1-NRF2 pathway reportedly prevents NRF2 degradation, and the accumulation of NRF2 has been reported to protect against ferroptosis in hepatocellular carcinoma cells (Figure 1)[24]. Here, NFE2L2 is linked to hepatocellular carcinoma.